Lawrence Tamarkin
CEO
Oncology
Cytimmune
United States of America
Biography
Dr. Lawrence Tamarkin, also known as Larry, Ph.D, , founded Cytimmune Sciences Inc. in 1988 and serves as its Chairman, Chief Executive Officer and President. Dr. Tamarkin was Chief of the Psychoneuroimmunology Program at the National Institute of Mental Health. Dr. Tamarkin also held research scientist positions in the NCI and the National Institute of Child Health and Human Development. He also was an Associate Research Professor of veterinary medicine at the University of Maryland, College Park. His publications include articles in the areas of cancer, pediatrics, and psychiatry, using ELISA technology, radioimmunoassays, biochemistry, cell biology, physiology and molecular biology, and he is the co-inventor of technology covered by eight issued patents and a number of pending patents. Dr. Tamarkin led CytImmune from its founding focus as a diagnostic company to a therapeutic company. In 1996, Dr. Tamarkin started channeling some of the revenue from the sale of kits to support to CytImmune’s therapeutic research efforts, in effect re-inventing CytImmune. Dr. Tamarkin graduated from S.U.N.Y at Stony Brook and received his Ph.D. from the University of Connecticut.
Research Interest
Oncology